Effect of Carvedilol on Oxidative Stress in Rabbits with Driamycin Cardiomyopathy
贺莉,肖建明,付晖,肖幸,肖志超,张存泰,顾晔,马业新
DOI: https://doi.org/10.13201/j.issn.1001-1439.2012.02.011
2012-01-01
Abstract:Objective:To investigate the effect of carvedilol on oxidative stress in rabbits with adriamycin cardiomyopathy and the relationship between oxidative stress and adriamycin cardiomyopathy. Method:Forty Japanese white rabbits were randomly divided into four groups(n=10 each): control group,adriamycin group,metoprolol group and carvedilol group.Rabbits in the adriamycin group,metoprolol group and carvedilol group were intravenously injected through auri-edge with adriamycin hydrochloride(1 ml·kg-1) twice a week for eight weeks to establish animal model of adriamycin cardiomyopathy,and the control group was injected with equal volume of saline at the same timepoint.Then,rabbits in the metoprolol group and the carvedilol group were intragastric administration with metoprolol(5 mg·kg-1·d-1) and carvedilol(5 mg·kg-1·d-1) respectively,and those in the control group and the adriamycin group were intragastric administration with equal volume of saline.Two months later,left ventricular end diastolic diameter(LVEDd) and left ventricular ejection fraction(LVEF) were measured by echocardiogram.Plasma levels of N-terminal pro brain-type natriuretic peptide(NT-proBNP),superoxide dismutase(SOD) and malondialdehyde(MAD) were measured and the wedge preparations from the rabbit hearts were perfused with Tyrode's solution,and ventricular arrhythmias were recorded. Result:LVEDd and the serum MDA,NT-proBNP increased,whereas LVEF and the serum SOD decreased in the adriamycin group compared with the control group.The incidences of ventricular arrhythmias were significantly higher in the adriamycin group than those in the control group(P0.05).Carvedilol increased serum SOD and LVEF,decreased MDA,NT-proBNP and LVEDd,inhibited the increase of incidences of ventricular arrhythmias(P0.05). Conclusion:Com-pared to metoprolol,carvedilol has protective function to adriamycin cardiomyopathy and can decrease occurrenceof ventricular arrthymia whose mechanism is closely related to decrease of oxidative free radicals.